Literature DB >> 34918776

Expression of CXCL12 in esophageal high grade dysplasia characterized pathologically by lymphocyte accumulation directly under the lesion.

Kunio Mochizuki1, Naoki Oishi2, Toru Odate2, Ippei Tahara2, Tomohiro Inoue2, Kazunari Kasai2, Tetsuo Kondo2.   

Abstract

Squamous dysplasia of the esophagus is an unequivocal neoplastic alteration of the esophageal squamous epithelium without invasion. Esophageal high grade dysplasia (EHGD) is characterized by >50% epithelial involvement or severe cytological atypia. Frequently, lymphocytes accumulate below EHGD lesions even though there is no invasion. If this lymphocytic accumulation is active, a transmitter should exist between the EHGD cells and the lymphocytes. C-X-C motif chemokine ligand (CXCL) 12, CXCL10 and C-C motif chemokine ligand 18 (CCL18) are all lymphocyte chemoattractants in vivo, but there are no reports on the relationship between these chemokines and EHGDs. In this study, we investigated these chemokines and C-X-C motif chemokine receptor 4 (CXCR4) (receptor for CXCL12) in 30 EHGDs using immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR). For comparison, we enrolled 30 samples of normal esophageal squamous epithelium (NESE). We confirmed CXCL12 expression (H-score≥50 points) in 70% of EHGD and 0% of NESE samples, CXCL10 expression in 3% of EHGD and 3% of NESE samples, CCL18 expression in 3% of EHGD and 0% of NESE samples, and CXCR4 expression in 53% of EHGD and 0% of NESE samples by immunohistochemistry. EHGD and NESE cases were significantly different in their expressions between the tissue types (CXCL12, p<0.001; CXCR4, p<0.001). We examined CXCL12 and CXCR4 mRNA expressions of 3 representative EHGD samples, each having their respective immunostained areas detected by RT-PCR. Finding CXCL12 expression may indicate that this chemokine plays a part in the lymphocyte accumulation that occurs directly under EHGDs.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34918776     DOI: 10.14670/HH-18-410

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  13 in total

1.  The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes.

Authors:  E Lindhout; J L Vissers; F C Hartgers; R J Huijbens; N M Scharenborg; C G Figdor; G J Adema
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 2.  The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease.

Authors:  Nathan Karin
Journal:  J Leukoc Biol       Date:  2010-05-25       Impact factor: 4.962

3.  Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms.

Authors:  Elisa Specht; Daniel Kaemmerer; Jörg Sänger; Ralph M Wirtz; Stefan Schulz; Amelie Lupp
Journal:  Histopathology       Date:  2015-03-23       Impact factor: 5.087

Review 4.  The unique structural and functional features of CXCL12.

Authors:  Rik Janssens; Sofie Struyf; Paul Proost
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

5.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

6.  Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.

Authors:  Ken Sasaki; Shoji Natsugoe; Sumiya Ishigami; Masataka Matsumoto; Hiroshi Okumura; Tetsuro Setoyama; Yasuto Uchikado; Yoshiaki Kita; Kiyokazu Tamotsu; Koichi Hanazono; Tetsuhiro Owaki; Takashi Aikou
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

Review 7.  The role of CXCL12 in tumor microenvironment.

Authors:  Wenfang Meng; Shihang Xue; Ye Chen
Journal:  Gene       Date:  2017-10-07       Impact factor: 3.688

8.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

9.  Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.

Authors:  Jinyan Liu; Feng Li; Yu Ping; Liping Wang; Xinfeng Chen; Dan Wang; Ling Cao; Song Zhao; Bing Li; Pawel Kalinski; Stephen H Thorne; Bin Zhang; Yi Zhang
Journal:  Oncotarget       Date:  2015-09-22

Review 10.  A meta-analysis of CXCL12 expression for cancer prognosis.

Authors:  Harsh Samarendra; Keaton Jones; Tatjana Petrinic; Michael A Silva; Srikanth Reddy; Zahir Soonawalla; Alex Gordon-Weeks
Journal:  Br J Cancer       Date:  2017-05-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.